Origin Life Sciences, Inc. (OLSI)

Origin Life Sciences will go public soon, but the exact IPO date is still unknown.

IPO Price

$4.00

Shares Offered

1,875,000

Deal Size

$7.50M

Origin Life Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Selling, General & Admin	2.88	2.88	6.38
Research & Development	0.05	0.05	0.01
Other Operating Expenses	0.09	0.09	0.09
Operating Expenses	3.02	3.02	6.48
Operating Income	-3.02	-3.02	-6.48
Interest Expense / Income	0.11	0.11	0.05
Other Expense / Income	5.7	5.7	-0.2
Pretax Income	-8.84	-8.84	-6.33
Net Income	-8.84	-8.84	-6.33
Free Cash Flow	-1.36	-1.36	-0.92
EBITDA	-8.63	-8.63	-6.19
Depreciation & Amortization	0.09	0.09	0.09
EBIT	-8.73	-8.73	-6.28

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).